Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 09 1995, 583-589, Vol 2, No. 5
M Morita, T Suzuki, K Nakajima, C Shiozawa, MJ Gill and H Hoshino
Antibodies against reverse transcriptase (RT) of human immunodeficiency
virus type 1 (HIV-1) have been detected in seropositive subjects by
immunoprecipitation, Western immunoblotting, and neutralization assay.
Recently, we noticed that the antibodies against RT stabilized RT upon heat
inactivation, and we have developed a stabilization assay of RT antibody.
Briefly, the RT of HIV-1 is completely inactivated by incubation at 56
degrees C for 20 min, but this inactivation is inhibited in the presence of
a specific antibody directed against this molecule. We examined the
specificity and clinical significance of this stabilization assay. HIV-1
antibody-positive sera stabilized HIV-1 RT but not HIV-2 RT, whereas half
of these sera cross-neutralized HIV-2 RT. Antibody titers against RT
determined by the neutralization assay and the stabilization assay were
compared with clinical characteristics. Antibodies against HIV-1 RT were
much more frequently detected by the stabilization assay than by the
neutralization assay. Statistically significant associations were found
between stabilizing antibody titer and CD4+ cell number in peripheral blood
of patients and also between antibody titer and CD4+/CD8+ ratios. These
results indicate that our new stabilization assay to detect specific
antibodies against RT of HIV-1 is useful as a clinical marker of infection
and progress of the disease.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Characteristics and clinical significance of a stabilization assay to detect specific antibodies to reverse transcriptase of human immunodeficiency virus
Division of Biomedical Research, Kitasato Institute Hospital, Tokyo, Japan.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |